Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 50 entries
Sorted by: Best Match Show Resources per page
Cation and anion transport in a dicationic imidazolium-based plastic crystal ion conductor.

The journal of physical chemistry. B

Kidd BE, Lingwood MD, Lee M, Gibson HW, Madsen LA.
PMID: 24495282
J Phys Chem B. 2014 Feb 27;118(8):2176-85. doi: 10.1021/jp4084629. Epub 2014 Feb 18.

Here we investigate the organic ionic plastic crystal 1,2-bis[N-(N'-hexylimidazolium-d2(4,5))]ethane 2PF6(-) in one of its solid plastic crystal phases by means of multinuclear solid-state (SS) NMR and pulsed-field-gradient NMR diffusometry. We quantify distinct cation and anion diffusion coefficients as well...

Cite
Kidd BE, Lingwood MD, Lee M, et al. Cation and anion transport in a dicationic imidazolium-based plastic crystal ion conductor. J Phys Chem B. 2014;118(8):2176-85doi: 10.1021/jp4084629.
Kidd, B. E., Lingwood, M. D., Lee, M., Gibson, H. W., & Madsen, L. A. (2014). Cation and anion transport in a dicationic imidazolium-based plastic crystal ion conductor. The journal of physical chemistry. B, 118(8), 2176-85. https://doi.org/10.1021/jp4084629
Kidd, Bryce E, et al. "Cation and anion transport in a dicationic imidazolium-based plastic crystal ion conductor." The journal of physical chemistry. B vol. 118,8 (2014): 2176-85. doi: https://doi.org/10.1021/jp4084629
Kidd BE, Lingwood MD, Lee M, Gibson HW, Madsen LA. Cation and anion transport in a dicationic imidazolium-based plastic crystal ion conductor. J Phys Chem B. 2014 Feb 27;118(8):2176-85. doi: 10.1021/jp4084629. Epub 2014 Feb 18. PMID: 24495282.
Copy Download .nbib Format: NLM
The μPIVOT: an integrated particle image velocimeter and optical tweezers instrument for microenvironment investigations.

Measurement science & technology

Nève N, Lingwood JK, Zimmerman J, Kohles SS, Tretheway DC.
PMID: 18953424
Meas Sci Technol. 2008;19(9):95403. doi: 10.1088/0957-0233/19/9/095403.

A novel instrument to manipulate and characterize the mechanical environment in and around microscale objects in a fluidic environment has been developed by integrating two laser-based techniques: micron-resolution particle image velocimetry (μPIV) and optical tweezers (OT). This instrument, the...

Cite
Nève N, Lingwood JK, Zimmerman J, et al. The μPIVOT: an integrated particle image velocimeter and optical tweezers instrument for microenvironment investigations. Meas Sci Technol. 2008;19(9):95403doi: 10.1088/0957-0233/19/9/095403.
Nève, N., Lingwood, J. K., Zimmerman, J., Kohles, S. S., & Tretheway, D. C. (2008). The μPIVOT: an integrated particle image velocimeter and optical tweezers instrument for microenvironment investigations. Measurement science & technology, 19(9), 95403. https://doi.org/10.1088/0957-0233/19/9/095403
Nève, N, et al. "The μPIVOT: an integrated particle image velocimeter and optical tweezers instrument for microenvironment investigations." Measurement science & technology vol. 19,9 (2008): 95403. doi: https://doi.org/10.1088/0957-0233/19/9/095403
Nève N, Lingwood JK, Zimmerman J, Kohles SS, Tretheway DC. The μPIVOT: an integrated particle image velocimeter and optical tweezers instrument for microenvironment investigations. Meas Sci Technol. 2008;19(9):95403. doi: 10.1088/0957-0233/19/9/095403. PMID: 18953424; PMCID: PMC2572229.
Copy Download .nbib Format: NLM
Plasma Leak From the Circulation Contributes to Poor Outcomes for Preterm Infants: A Working Hypothesis.

Frontiers in neurology

Eiby YA, Lingwood BE, Wright IMR.
PMID: 34408716
Front Neurol. 2021 Aug 02;12:636740. doi: 10.3389/fneur.2021.636740. eCollection 2021.

Preterm infants are at high risk of death and disability resulting from brain injury. Impaired cardiovascular function leading to poor cerebral oxygenation is a significant contributor to these adverse outcomes, but current therapeutic approaches have failed to improve outcome....

Cite
Eiby YA, Lingwood BE, Wright IMR. Plasma Leak From the Circulation Contributes to Poor Outcomes for Preterm Infants: A Working Hypothesis. Front Neurol. 2021;12:636740doi: 10.3389/fneur.2021.636740.
Eiby, Y. A., Lingwood, B. E., & Wright, I. M. R. (2021). Plasma Leak From the Circulation Contributes to Poor Outcomes for Preterm Infants: A Working Hypothesis. Frontiers in neurology, 12636740. https://doi.org/10.3389/fneur.2021.636740
Eiby, Yvonne A, et al. "Plasma Leak From the Circulation Contributes to Poor Outcomes for Preterm Infants: A Working Hypothesis." Frontiers in neurology vol. 12 (2021): 636740. doi: https://doi.org/10.3389/fneur.2021.636740
Eiby YA, Lingwood BE, Wright IMR. Plasma Leak From the Circulation Contributes to Poor Outcomes for Preterm Infants: A Working Hypothesis. Front Neurol. 2021 Aug 02;12:636740. doi: 10.3389/fneur.2021.636740. eCollection 2021. PMID: 34408716; PMCID: PMC8364946.
Copy Download .nbib Format: NLM
Engineered receptor binding domain immunogens elicit pan-sarbecovirus neutralizing antibodies outside the receptor binding motif.

bioRxiv : the preprint server for biology

Hauser BM, Sangesland M, Lam EC, Denis KJS, Feldman J, Yousif AS, Caradonna TM, Kannegieter T, Balazs AB, Lingwood D, Schmidt AG.
PMID: 33330872
bioRxiv. 2021 Jun 29; doi: 10.1101/2020.12.07.415216.

Effective countermeasures are needed against emerging coronaviruses of pandemic potential, similar to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Designing immunogens that elicit broadly neutralizing antibodies to conserved viral epitopes on the major surface glycoprotein, spike, such as the...

Cite
Hauser BM, Sangesland M, Lam EC, et al. Engineered receptor binding domain immunogens elicit pan-sarbecovirus neutralizing antibodies outside the receptor binding motif. bioRxiv. 2021;doi: 10.1101/2020.12.07.415216.
Hauser, B. M., Sangesland, M., Lam, E. C., Denis, K. J. S., Feldman, J., Yousif, A. S., Caradonna, T. M., Kannegieter, T., Balazs, A. B., Lingwood, D., & Schmidt, A. G. (2021). Engineered receptor binding domain immunogens elicit pan-sarbecovirus neutralizing antibodies outside the receptor binding motif. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2020.12.07.415216
Hauser, Blake M, et al. "Engineered receptor binding domain immunogens elicit pan-sarbecovirus neutralizing antibodies outside the receptor binding motif." bioRxiv : the preprint server for biology vol. (2021). doi: https://doi.org/10.1101/2020.12.07.415216
Hauser BM, Sangesland M, Lam EC, Denis KJS, Feldman J, Yousif AS, Caradonna TM, Kannegieter T, Balazs AB, Lingwood D, Schmidt AG. Engineered receptor binding domain immunogens elicit pan-sarbecovirus neutralizing antibodies outside the receptor binding motif. bioRxiv. 2021 Jun 29; doi: 10.1101/2020.12.07.415216. PMID: 33330872; PMCID: PMC7743097.
Copy Download .nbib Format: NLM
COVID-19 neutralizing antibodies predict disease severity and survival.

medRxiv : the preprint server for health sciences

Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, Hauser BM, Caradonna TM, Clayton KL, Nitido AD, Murali MR, Alter G, Charles RC, Dighe A, Branda JA, Lennerz JK, Lingwood D, Schmidt AG, Iafrate AJ, Balazs AB.
PMID: 33106822
medRxiv. 2020 Oct 20; doi: 10.1101/2020.10.15.20213512.

COVID-19 exhibits variable symptom severity ranging from asymptomatic to life-threatening, yet the relationship between severity and the humoral immune response is poorly understood. We examined antibody responses in 113 COVID-19 patients and found that severe cases resulting in intubation...

Cite
Garcia-Beltran WF, Lam EC, Astudillo MG, et al. COVID-19 neutralizing antibodies predict disease severity and survival. medRxiv. 2020;doi: 10.1101/2020.10.15.20213512.
Garcia-Beltran, W. F., Lam, E. C., Astudillo, M. G., Yang, D., Miller, T. E., Feldman, J., Hauser, B. M., Caradonna, T. M., Clayton, K. L., Nitido, A. D., Murali, M. R., Alter, G., Charles, R. C., Dighe, A., Branda, J. A., Lennerz, J. K., Lingwood, D., Schmidt, A. G., Iafrate, A. J., & Balazs, A. B. (2020). COVID-19 neutralizing antibodies predict disease severity and survival. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2020.10.15.20213512
Garcia-Beltran, Wilfredo F, et al. "COVID-19 neutralizing antibodies predict disease severity and survival." medRxiv : the preprint server for health sciences vol. (2020). doi: https://doi.org/10.1101/2020.10.15.20213512
Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, Hauser BM, Caradonna TM, Clayton KL, Nitido AD, Murali MR, Alter G, Charles RC, Dighe A, Branda JA, Lennerz JK, Lingwood D, Schmidt AG, Iafrate AJ, Balazs AB. COVID-19 neutralizing antibodies predict disease severity and survival. medRxiv. 2020 Oct 20; doi: 10.1101/2020.10.15.20213512. PMID: 33106822; PMCID: PMC7587842.
Copy Download .nbib Format: NLM
Engineering an Antibody V Gene-Selective Vaccine.

Frontiers in immunology

Ronsard L, Yousif AS, Peabody J, Okonkwo V, Devant P, Mogus AT, Barnes RM, Rohrer D, Lonberg N, Peabody D, Chackerian B, Lingwood D.
PMID: 34566992
Front Immunol. 2021 Sep 09;12:730471. doi: 10.3389/fimmu.2021.730471. eCollection 2021.

The ligand-binding surface of the B cell receptor (BCR) is formed by encoded and non-encoded antigen complementarity determining regions (CDRs). Genetically reproducible or 'public' antibodies can arise when the encoded CDRs play deterministic roles in antigen recognition, notably within...

Cite
Ronsard L, Yousif AS, Peabody J, et al. Engineering an Antibody V Gene-Selective Vaccine. Front Immunol. 2021;12:730471doi: 10.3389/fimmu.2021.730471.
Ronsard, L., Yousif, A. S., Peabody, J., Okonkwo, V., Devant, P., Mogus, A. T., Barnes, R. M., Rohrer, D., Lonberg, N., Peabody, D., Chackerian, B., & Lingwood, D. (2021). Engineering an Antibody V Gene-Selective Vaccine. Frontiers in immunology, 12730471. https://doi.org/10.3389/fimmu.2021.730471
Ronsard, Larance, et al. "Engineering an Antibody V Gene-Selective Vaccine." Frontiers in immunology vol. 12 (2021): 730471. doi: https://doi.org/10.3389/fimmu.2021.730471
Ronsard L, Yousif AS, Peabody J, Okonkwo V, Devant P, Mogus AT, Barnes RM, Rohrer D, Lonberg N, Peabody D, Chackerian B, Lingwood D. Engineering an Antibody V Gene-Selective Vaccine. Front Immunol. 2021 Sep 09;12:730471. doi: 10.3389/fimmu.2021.730471. eCollection 2021. PMID: 34566992; PMCID: PMC8459710.
Copy Download .nbib Format: NLM
Public Immunity: Evolutionary Spandrels for Pathway-Amplifying Protective Antibodies.

Frontiers in immunology

Sangesland M, Lingwood D.
PMID: 34956170
Front Immunol. 2021 Dec 09;12:708882. doi: 10.3389/fimmu.2021.708882. eCollection 2021.

Humoral immunity is seeded by affinity between the B cell receptor (BCR) and cognate antigen. While the BCR is a chimeric display of diverse antigen engagement solutions, we discuss its functional activity as an 'innate-like' immune receptor, wherein genetically...

Cite
Sangesland M, Lingwood D. Public Immunity: Evolutionary Spandrels for Pathway-Amplifying Protective Antibodies. Front Immunol. 2021;12:708882doi: 10.3389/fimmu.2021.708882.
Sangesland, M., & Lingwood, D. (2021). Public Immunity: Evolutionary Spandrels for Pathway-Amplifying Protective Antibodies. Frontiers in immunology, 12708882. https://doi.org/10.3389/fimmu.2021.708882
Sangesland, Maya, and Lingwood, Daniel. "Public Immunity: Evolutionary Spandrels for Pathway-Amplifying Protective Antibodies." Frontiers in immunology vol. 12 (2021): 708882. doi: https://doi.org/10.3389/fimmu.2021.708882
Sangesland M, Lingwood D. Public Immunity: Evolutionary Spandrels for Pathway-Amplifying Protective Antibodies. Front Immunol. 2021 Dec 09;12:708882. doi: 10.3389/fimmu.2021.708882. eCollection 2021. PMID: 34956170; PMCID: PMC8696009.
Copy Download .nbib Format: NLM
Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for 'Universal' Influenza Vaccines.

Vaccines

Sangesland M, Lingwood D, Häkli J.
PMID: 33562627
Vaccines (Basel). 2021 Feb 05;9(2). doi: 10.3390/vaccines9020125.

Influenza virus remains a serious public health burden due to ongoing viral evolution. Vaccination remains the best measure of prophylaxis, yet current seasonal vaccines elicit strain-specific neutralizing responses that favor the hypervariable epitopes on the virus. This necessitates yearly...

Cite
Sangesland M, Lingwood D, Häkli J. Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for 'Universal' Influenza Vaccines. Vaccines (Basel). 2021;9(2)doi: 10.3390/vaccines9020125.
Sangesland, M., Lingwood, D., & Häkli, J. (2021). Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for 'Universal' Influenza Vaccines. Vaccines, 9(2), . https://doi.org/10.3390/vaccines9020125
Sangesland, Maya, et al. "Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for 'Universal' Influenza Vaccines." Vaccines vol. 9,2 (2021). doi: https://doi.org/10.3390/vaccines9020125
Sangesland M, Lingwood D, Häkli J. Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for 'Universal' Influenza Vaccines. Vaccines (Basel). 2021 Feb 05;9(2). doi: 10.3390/vaccines9020125. PMID: 33562627; PMCID: PMC7914524.
Copy Download .nbib Format: NLM
Rationally designed immunogens enable immune focusing to the SARS-CoV-2 receptor binding motif.

bioRxiv : the preprint server for biology

Hauser BM, Sangesland M, Denis KJS, Windsor IW, Feldman J, Lam EC, Kannegieter T, Balazs AB, Lingwood D, Schmidt AG.
PMID: 33758851
bioRxiv. 2021 Jul 09; doi: 10.1101/2021.03.15.435440.

Eliciting antibodies to surface-exposed viral glycoproteins can lead to protective responses that ultimately control and prevent future infections. Targeting functionally conserved epitopes may help reduce the likelihood of viral escape and aid in preventing the spread of related viruses...

Cite
Hauser BM, Sangesland M, Denis KJS, et al. Rationally designed immunogens enable immune focusing to the SARS-CoV-2 receptor binding motif. bioRxiv. 2021;doi: 10.1101/2021.03.15.435440.
Hauser, B. M., Sangesland, M., Denis, K. J. S., Windsor, I. W., Feldman, J., Lam, E. C., Kannegieter, T., Balazs, A. B., Lingwood, D., & Schmidt, A. G. (2021). Rationally designed immunogens enable immune focusing to the SARS-CoV-2 receptor binding motif. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2021.03.15.435440
Hauser, Blake M, et al. "Rationally designed immunogens enable immune focusing to the SARS-CoV-2 receptor binding motif." bioRxiv : the preprint server for biology vol. (2021). doi: https://doi.org/10.1101/2021.03.15.435440
Hauser BM, Sangesland M, Denis KJS, Windsor IW, Feldman J, Lam EC, Kannegieter T, Balazs AB, Lingwood D, Schmidt AG. Rationally designed immunogens enable immune focusing to the SARS-CoV-2 receptor binding motif. bioRxiv. 2021 Jul 09; doi: 10.1101/2021.03.15.435440. PMID: 33758851; PMCID: PMC7987010.
Copy Download .nbib Format: NLM
Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Das Adhikari U, Eng G, Farcasanu M, Avena LE, Choudhary MC, Triant VA, Flagg M, Schiff AE, Gomez I, Froehle LM, Diefenbach TJ, Ronsard L, Lingwood D, Lee GC, Rabi SA, Erstad D, Velmahos G, Li JZ, Hodin R, Stone JR, Honko AN, Griffiths A, Yilmaz O, Kwon DS.
PMID: 34245255
Clin Infect Dis. 2021 Jul 10; doi: 10.1093/cid/ciab623. Epub 2021 Jul 10.

The clinical significance of SARS CoV-2 RNA in stool remains uncertain. We found that extrapulmonary dissemination of infection to the gastrointestinal (GI) tract, assessed by the presence of SARS-CoV-2 RNA in stool, is associated with decreased COVID-19 survival. Measurement...

Cite
Das Adhikari U, Eng G, Farcasanu M, et al. Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival. Clin Infect Dis. 2021;doi: 10.1093/cid/ciab623.
Das Adhikari, U., Eng, G., Farcasanu, M., Avena, L. E., Choudhary, M. C., Triant, V. A., Flagg, M., Schiff, A. E., Gomez, I., Froehle, L. M., Diefenbach, T. J., Ronsard, L., Lingwood, D., Lee, G. C., Rabi, S. A., Erstad, D., Velmahos, G., Li, J. Z., Hodin, R., Stone, J. R., Honko, A. N., Griffiths, A., Yilmaz, O., & Kwon, D. S. (2021). Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, . https://doi.org/10.1093/cid/ciab623
Das Adhikari, Upasana, et al. "Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. (2021). doi: https://doi.org/10.1093/cid/ciab623
Das Adhikari U, Eng G, Farcasanu M, Avena LE, Choudhary MC, Triant VA, Flagg M, Schiff AE, Gomez I, Froehle LM, Diefenbach TJ, Ronsard L, Lingwood D, Lee GC, Rabi SA, Erstad D, Velmahos G, Li JZ, Hodin R, Stone JR, Honko AN, Griffiths A, Yilmaz O, Kwon DS. Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival. Clin Infect Dis. 2021 Jul 10; doi: 10.1093/cid/ciab623. Epub 2021 Jul 10. PMID: 34245255; PMCID: PMC8406863.
Copy Download .nbib Format: NLM
Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses.

bioRxiv : the preprint server for biology

Feldman J, Bals J, Altomare CG, St Denis K, Lam EC, Hauser BM, Ronsard L, Sangesland M, Moreno TB, Okonkwo V, Hartojo N, Balazs AB, Bajic G, Lingwood D, Schmidt AG.
PMID: 33594359
bioRxiv. 2021 Jul 09; doi: 10.1101/2021.02.02.429458.

Exposure to a pathogen elicits an adaptive immune response aimed to control and eradicate. Interrogating the abundance and specificity of the naive B cell repertoire contributes to understanding how to potentially elicit protective responses. Here, we isolated naive B...

Cite
Feldman J, Bals J, Altomare CG, et al. Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses. bioRxiv. 2021;doi: 10.1101/2021.02.02.429458.
Feldman, J., Bals, J., Altomare, C. G., St Denis, K., Lam, E. C., Hauser, B. M., Ronsard, L., Sangesland, M., Moreno, T. B., Okonkwo, V., Hartojo, N., Balazs, A. B., Bajic, G., Lingwood, D., & Schmidt, A. G. (2021). Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2021.02.02.429458
Feldman, Jared, et al. "Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses." bioRxiv : the preprint server for biology vol. (2021). doi: https://doi.org/10.1101/2021.02.02.429458
Feldman J, Bals J, Altomare CG, St Denis K, Lam EC, Hauser BM, Ronsard L, Sangesland M, Moreno TB, Okonkwo V, Hartojo N, Balazs AB, Bajic G, Lingwood D, Schmidt AG. Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses. bioRxiv. 2021 Jul 09; doi: 10.1101/2021.02.02.429458. PMID: 33594359; PMCID: PMC7885909.
Copy Download .nbib Format: NLM
Public Immunity: Evolutionary Spandrels for Pathway-Amplifying Protective Antibodies.

Frontiers in immunology

Sangesland M, Lingwood D.
PMID: 34956170
Front Immunol. 2021 Dec 09;12:708882. doi: 10.3389/fimmu.2021.708882. eCollection 2021.

Humoral immunity is seeded by affinity between the B cell receptor (BCR) and cognate antigen. While the BCR is a chimeric display of diverse antigen engagement solutions, we discuss its functional activity as an 'innate-like' immune receptor, wherein genetically...

Cite
Sangesland M, Lingwood D. Public Immunity: Evolutionary Spandrels for Pathway-Amplifying Protective Antibodies. Front Immunol. 2021;12:708882doi: 10.3389/fimmu.2021.708882.
Sangesland, M., & Lingwood, D. (2021). Public Immunity: Evolutionary Spandrels for Pathway-Amplifying Protective Antibodies. Frontiers in immunology, 12708882. https://doi.org/10.3389/fimmu.2021.708882
Sangesland, Maya, and Lingwood, Daniel. "Public Immunity: Evolutionary Spandrels for Pathway-Amplifying Protective Antibodies." Frontiers in immunology vol. 12 (2021): 708882. doi: https://doi.org/10.3389/fimmu.2021.708882
Sangesland M, Lingwood D. Public Immunity: Evolutionary Spandrels for Pathway-Amplifying Protective Antibodies. Front Immunol. 2021 Dec 09;12:708882. doi: 10.3389/fimmu.2021.708882. eCollection 2021. PMID: 34956170; PMCID: PMC8696009.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 50 entries